Chris Takimoto
Chief Tech/Sci/R&D Officer bei IGM BIOSCIENCES, INC.
Vermögen: 910 844 $ am 31.03.2024
Aktive Positionen von Chris Takimoto
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IGM BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 29.07.2021 | - |
Karriereverlauf von Chris Takimoto
Ehemalige bekannte Positionen von Chris Takimoto
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.04.2020 | 01.07.2021 |
FORTY SEVEN, INC. | Chief Tech/Sci/R&D Officer | 01.02.2016 | 01.04.2020 |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Corporate Officer/Principal | 01.09.2010 | 01.01.2016 |
Ortho Biotech Oncology Research & Development | Corporate Officer/Principal | 01.01.2008 | 01.01.2010 |
University of Texas Health Science Center At San Antonio | Corporate Officer/Principal | 01.01.2000 | - |
Ausbildung von Chris Takimoto
Stanford University | Undergraduate Degree |
Yale University | Doctorate Degree |
Yale School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Operativ
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
IGM BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Forty Seven, Inc.
Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
Ortho Biotech Oncology Research & Development | |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Health Technology |
- Börse
- Insiders
- Chris Takimoto
- Erfahrung